Garber F - Search Results

1

Positional effects on exophthalmometer readings in Graves' eye disease.

Frueh BR, Garber F, Grill R, Musch DC. Frueh BR, et al. Among authors: garber f. Arch Ophthalmol. 1985 Sep;103(9):1355-6. doi: 10.1001/archopht.1985.01050090107043. Arch Ophthalmol. 1985. PMID: 3840014

2

Exophthalmometer readings in patients with Graves' eye disease.

Frueh BR, Musch DC, Garber FW. Frueh BR, et al. Among authors: garber fw. Ophthalmic Surg. 1986 Jan;17(1):37-40. Ophthalmic Surg. 1986. PMID: 3754041

3

Orbital compliance in Graves' eye disease.

Frueh BR, Musch DC, Grill R, Garber FW, Hamby S. Frueh BR, et al. Among authors: garber fw. Ophthalmology. 1985 May;92(5):657-65. doi: 10.1016/s0161-6420(85)33990-8. Ophthalmology. 1985. PMID: 3839299

4

The effects of Graves' eye disease on levator muscle function.

Frueh BR, Garber FW, Musch DC. Frueh BR, et al. Among authors: garber fw. Ophthalmic Surg. 1986 Mar;17(3):142-5. Ophthalmic Surg. 1986. PMID: 3754320

5

Lid retraction and levator aponeurosis defects in Graves' eye disease.

Frueh BR, Musch DC, Garber FW. Frueh BR, et al. Among authors: garber fw. Ophthalmic Surg. 1986 Apr;17(4):216-20. Ophthalmic Surg. 1986. PMID: 3754942

6

Margins of safety in lateral orbitotomy.

Simonton JT, Garber F, Ahl N. Simonton JT, et al. Among authors: garber f. Arch Ophthalmol. 1977 Jul;95(7):1229-31. doi: 10.1001/archopht.1977.04450070127012. Arch Ophthalmol. 1977. PMID: 880084

7

Comparative Analysis of LC-ESI-IM-qToF-MS and FT-NIR Spectroscopy Approaches for the Authentication of Organic and Conventional Eggs.

Lösel H, Brockelt J, Gärber F, Teipel J, Kuballa T, Seifert S, Fischer M. Lösel H, et al. Among authors: garber f. Metabolites. 2023 Jul 25;13(8):882. doi: 10.3390/metabo13080882. Metabolites. 2023. PMID: 37623826 Free PMC article.

8

A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.

Jackson TL, Slakter J, Buyse M, Wang K, Dugel PU, Wykoff CC, Boyer DS, Gerometta M, Baldwin ME, Price CF; Opthea Study Group Investigators. Jackson TL, et al. Ophthalmology. 2023 Jun;130(6):588-597. doi: 10.1016/j.ophtha.2023.02.001. Epub 2023 Feb 6. Ophthalmology. 2023. PMID: 36754174 Free article. Clinical Trial.

9

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.

Hutton DW, Glassman AR, Liu D, Sun JK; DRCR Retina Network. Hutton DW, et al. JAMA Ophthalmol. 2023 Mar 1;141(3):268-274. doi: 10.1001/jamaophthalmol.2022.6142. JAMA Ophthalmol. 2023. PMID: 36729431 Free PMC article. Clinical Trial.

10

Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.

Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page